PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 51 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $291,000 | +20.2% | 212,493 | 0.0% | 0.00% | – |
| Q1 2020 | $242,000 | -50.0% | 212,493 | 0.0% | 0.00% | – |
| Q4 2019 | $484,000 | +168.9% | 212,493 | 0.0% | 0.00% | – |
| Q3 2019 | $180,000 | -9.5% | 212,493 | 0.0% | 0.00% | – |
| Q2 2019 | $199,000 | -28.7% | 212,493 | -3.8% | 0.00% | – |
| Q1 2019 | $279,000 | -61.0% | 220,859 | -0.2% | 0.00% | – |
| Q4 2018 | $716,000 | +36.1% | 221,252 | +1.3% | 0.00% | – |
| Q3 2018 | $526,000 | -13.3% | 218,422 | +0.4% | 0.00% | – |
| Q2 2018 | $607,000 | -39.8% | 217,604 | +2.4% | 0.00% | – |
| Q1 2018 | $1,009,000 | -18.6% | 212,493 | -0.1% | 0.00% | – |
| Q4 2017 | $1,240,000 | -47.5% | 212,643 | -81.1% | 0.00% | -100.0% |
| Q3 2017 | $2,361,000 | +135.9% | 1,124,602 | +425.4% | 0.00% | – |
| Q2 2017 | $1,001,000 | -66.2% | 214,052 | -43.4% | 0.00% | -100.0% |
| Q1 2017 | $2,959,000 | +40.7% | 378,368 | +120.5% | 0.00% | 0.0% |
| Q4 2016 | $2,103,000 | -21.9% | 171,557 | -0.6% | 0.00% | 0.0% |
| Q3 2016 | $2,692,000 | +253.3% | 172,650 | +174.7% | 0.00% | – |
| Q2 2016 | $762,000 | +20.6% | 62,850 | -4.2% | 0.00% | – |
| Q1 2016 | $632,000 | – | 65,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|